Free Cash Flow per Share: A measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Calculated as: Free Cash Flow / Weighted Average Shares Outstanding (Diluted)
Kiniksa Pharmaceuticals International, plc (KNSA) had Free Cash Flow per Share of $0.36 for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
$423.24M |
|
$-43.19M |
|
$60.91M |
|
$362.33M |
|
$468.86M |
|
$-45.62M |
|
$9.46M |
|
$-36.15M |
|
$-36.15M |
|
$-43.19M |
|
$-43.19M |
|
$-43.19M |
|
$-43.19M |
|
$-45.62M |
|
$-43.92M |
|
71.42M |
|
71.42M |
|
$-0.60 |
|
$-0.60 |
|
| Balance Sheet Financials | |
$331.80M |
|
$0.66M |
|
$248.75M |
|
$580.55M |
|
$100.62M |
|
-- |
|
$41.50M |
|
$142.12M |
|
$438.44M |
|
$422.19M |
|
$438.44M |
|
72.52M |
|
| Cash Flow Statement Financials | |
$25.69M |
|
$37.67M |
|
$12.27M |
|
$107.95M |
|
$183.58M |
|
$75.63M |
|
$30.69M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.30 |
|
-- |
|
-- |
|
-- |
|
-- |
|
85.61% |
|
-10.78% |
|
-10.78% |
|
-10.38% |
|
-8.54% |
|
-10.21% |
|
$25.44M |
|
-- |
|
-- |
|
-- |
|
0.73 |
|
2.31 |
|
10.14 |
|
35.98 |
|
-9.85% |
|
-10.23% |
|
-7.44% |
|
-9.85% |
|
$6.05 |
|
|
Free Cash Flow per Share |
$0.36 |
$0.36 |
|